Coherus Announces Industry-Wide Lowest List Price for Adalimumab Biosimilar YUSIMRY™ (adalimumab-aqvh) Launching in July 2023

Source: Nasdaq GlobeNewswire / 01 Jun 2023 08:30:00   America/New_York